Even if retracted, published clinical trial reports that misrepresent findings, withhold negative data, or make false, or unsubstantiated claims have done irreparable damage. AHRP calls upon all medical journals to adopt a publication policy requiring submission of the sponsor’s formal Clinical Study Report to accompany articles about clinical trial findings.
Even as the corruption of science is no longer a dirty little secret, but is in plain sight, no one is doing anything tostop it. April 16, 2012 A Sharp Rise in Retractions Prompts Calls for Reform By CARL ZIMMER In . . . Continue reading →
Healthcare providers and insurers, in the pursuit of increased profits, have resorted to ruthless tactics befitting Mafia enforcers or loan sharks, when interfacing with patients. Continue reading →
An urgent call for a debate about the ethics of data secrecy. Absent the humanitarian raison d’etre for enrolling in a clinical trial, no human being should be put at any–even minimal risk–without adequate compensation as a laborer and the protection of Workmen’s Compensation insurance.
On Friday, April 6, the FDA approved another of Eli Lilly’s "breakthroughs" whose clinical value is questionable (at best). Continue reading →
The Centers for Disease Control issued an alarming report: 1 in 88 US children are afflicted with autism–an increase of 25% between 2006-2008.
“Overuse is one of the most serious crises in American medicine.” The crisis is not only of misspending of resources, overuse of medical treatments is causing treatment-produced harm, including preventable deaths.